THOMAS BOWEN: Open Payments
NPI 1619607264 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 7 payments from 5 companies in 2025. Trend: 2023 $59 · 2024 $167 · 2025 $600
Food & beverage: $600
| Company | Payments | Amount |
|---|---|---|
| Legend Biotech USA Inc. | 3 | $205 |
| GENZYME CORPORATION | 1 | $143 |
| Daiichi Sankyo Inc. | 1 | $138 |
| ABBVIE INC. | 1 | $82 |
| Incyte Corporation | 1 | $33 |
Products named: CARVYKTI, Vanflyta, IMBRUVICA, NIKTIMVO.
Industry payments across AZ — which companies pay providers there.
